![Blood Thinners for Atrial Fibrillation Stroke Prevention | Circulation: Arrhythmia and Electrophysiology Blood Thinners for Atrial Fibrillation Stroke Prevention | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/7adf6538-134a-423d-a58e-03880bc43900/circep.120.009389.fig01.jpg)
Blood Thinners for Atrial Fibrillation Stroke Prevention | Circulation: Arrhythmia and Electrophysiology
![Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2020/07/wc-3.png?resize=500%2C308&ssl=1)
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times](https://static01.nyt.com/images/2019/03/25/science/25BLOODTHINNER/25BLOODTHINNER-videoSixteenByNine3000.jpg?year=2019&h=1687&w=3000&s=f0f4f8af60beadcaf3843a973f9179f70193494ad832620257599453d55ce5b5&k=ZQJBKqZ0VN&tw=1)